UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000027738
Receipt No. R000031782
Scientific Title Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.
Date of disclosure of the study information 2017/07/01
Last modified on 2017/06/13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.
Acronym Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.
Scientific Title Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.
Scientific Title:Acronym Intention, attitude and hope to stop blood transfusion in advanced blood tumor patients.
Region
Japan

Condition
Condition hematological tumor
Classification by specialty
Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 We want to clarify intention, attitude and hope to stop blood transfusion in advanced blood tumor patients through personal interview.
Basic objectives2 Others
Basic objectives -Others We want to consider clinical guidelines about blood transfusion of advanced bllod tumor patients.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Intention and attitude to blood transfusion.
When do they want to stop blood transfusion. In that case, how to tell or be told medical staff about this hope.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Advanced blood tumor patients.
Patients who were told their disease is not curerable from the doctor.
Patients receiving regular blood transfusion.
Key exclusion criteria Patients who can not speak Japanese.
Patients who do not know anout their disease and future prospects.
Patients recieving temporary blood transfusion because of active bleeding and anemia.
Target sample size 30

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yoshiyuki Kizawa
Organization Kobe university graduate School of medicine
Division name Department of palliative medicine
Zip code
Address 7-5-1, Kusunokicho, Chuo-ku, Kobe, Hyogo, Japan
TEL 0783826531
Email kizawa-ysyk@umin.org

Public contact
Name of contact person
1st name
Middle name
Last name Asami Shimada
Organization Kobe university graduate School of medicine
Division name Department of palliative medicine
Zip code
Address 7-5-1, Kusunokicho, Chuo-ku, Kobe, Hyogo, Japan
TEL 0783826531
Homepage URL
Email ashimada@med.kobe-u.ac.jp

Sponsor
Institute Kobe university graduate School of medicine
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 06 Month 01 Day
Date of IRB
Anticipated trial start date
2017 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information none

Management information
Registered date
2017 Year 06 Month 13 Day
Last modified on
2017 Year 06 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031782

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.